| Use of Tuohy needle for intraamniotic methotrexate injection through the cervical canal in a cervical pregnancy after failure of systemic methotrexate treatment. | |
| | |
MedLine Citation:
|
PMID: 20452477 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A case of cervical pregnancy resistant to systemic methotrexate (MTX) administration is presented. A 41 year old patient with cervical pregnancy at 6 weeks 4 days' gestation was successfully treated by intraamniotic MTX injection through the cervical canal using Tuohy needle after failure of systemic MTX treatment. |
| | |
Authors:
|
Hwa Sook Moon; Jung Hwan Hyun; Kyung Seo Kim; Hyun Jung Kim; Sung Eun Moon; Ja Seong Koo |
Related Documents
:
|
6588967 - Pregnancy hydronephrosis--a longitudinal ultrasonic evaluation. 3473937 - Plasma concentrations of prostaglandin f2 alpha and prostaglandin e2 metabolites after ... 990217 - The effect of oxytocics on the human cervix during midtrimester pregnancy. 8725137 - "arias-stella reaction"-like changes in endocervical glandular epithelium in cervical s... 15714047 - Safety and efficacy of gabaergic medications for treating alcoholism. 2545077 - Cytochemical studies of peripheral blood leucocytes in pregnancy. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: American journal of obstetrics and gynecology Volume: 202 ISSN: 1097-6868 ISO Abbreviation: Am. J. Obstet. Gynecol. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-10 Completed Date: 2010-06-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370476 Medline TA: Am J Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: e4-6 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright (c) 2010 Mosby, Inc. All rights reserved. |
Affiliation:
|
Center for Minimally Invasive Surgery, Department of Obstetrics and Gynecology, Good Moonhwa Hospital, Busan, Korea. moonhwas@moonhwa.or.kr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
administration & dosage* Adult Cervix Uteri* Female Humans Injections Methotrexate / administration & dosage* Needles Pregnancy Pregnancy, Ectopic / drug therapy* Treatment Failure Uterine Hemorrhage / prevention & control |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic revie...
Next Document: Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predisp...